After injecting testosterone in a hypoandrogenic male, which of the following occurs ?
What is the effect of inhibin B hormone?
Enzyme that can be traced in semen sample of 8-10 weeks is:
What is the correct sequential order of sperm formation? 1. Spermatogonia 2. Spermatocyte 3. Spermatids 4. Spermatozoa
Which of the following is a cause of male infertility?
Pseudotumor cerebri is seen in -
What is the most likely consequence of prolonged testosterone treatment on male fertility?
Disruption of the hypothalamic-pituitary portal system will lead to
What is the mechanism by which hyperprolactinemia causes amenorrhea?
Where does meiosis occur in human females?
Explanation: ***Decreased FSH secretion*** - Exogenous testosterone administration leads to **negative feedback** on the hypothalamic-pituitary-gonadal axis, suppressing **GnRH** release, which in turn decreases both **LH** and **FSH** secretion. - FSH suppression is particularly clinically significant because it results in **inhibition of spermatogenesis**, which is a key consideration when using testosterone replacement therapy. - The decrease in FSH, combined with reduced **intratesticular testosterone** (due to LH suppression), impairs Sertoli cell function and sperm production. *Decreased LH secretion* - **This also occurs** with exogenous testosterone administration due to negative feedback on the hypothalamus and pituitary. - Testosterone primarily suppresses **LH** through direct negative feedback at the hypothalamic-pituitary level. - However, in the context of this question focusing on the consequences in a hypoandrogenic male receiving testosterone, the **FSH suppression** and its impact on spermatogenesis is the more clinically emphasized outcome. - **Note:** Both LH and FSH decrease; this question likely emphasizes FSH due to its role in fertility concerns with testosterone therapy. *Increased spermatogenesis* - This is **incorrect**. Exogenous testosterone actually **suppresses spermatogenesis** through multiple mechanisms: - Decreased **FSH** (essential for Sertoli cell function) - Decreased **intratesticular testosterone** concentration (despite high systemic levels) - The high local testosterone concentration within the seminiferous tubules (30-100x serum levels) cannot be achieved by systemic testosterone alone. *None of the options* - This is incorrect because exogenous testosterone administration clearly causes **suppression of gonadotropins** (both LH and FSH) through well-established negative feedback mechanisms.
Explanation: ***Inhibits FSH secretion from anterior pituitary*** - **Inhibin B** is a hormone produced by the **Sertoli cells** in males and **granulosa cells** in females. - Its primary function is to provide **negative feedback** to the anterior pituitary, specifically **inhibiting the release of follicle-stimulating hormone (FSH)**. *Stimulates Sertoli cell proliferation* - **FSH** (not inhibin B) is responsible for stimulating **Sertoli cell proliferation** and differentiation. - **Inhibin B** is produced by mature Sertoli cells, indicating their functional status rather than promoting their growth. *Directly stimulates seminiferous tubule development* - **FSH** and **testosterone** are the primary hormones crucial for the development and maintenance of the **seminiferous tubules**. - **Inhibin B** acts indirectly by regulating FSH, but it does not directly stimulate tubule development. *Directly enhances spermatogenesis rate* - While **inhibin B** production is correlated with the rate of spermatogenesis (it's high when spermatogenesis is active), it does not directly enhance the process. - **FSH** and **testosterone** are the direct hormonal regulators that enhance the rate of **spermatogenesis**.
Explanation: ***Acid phosphatase test*** - The **acid phosphatase (AP) test** is a crucial forensic test for identifying seminal fluid, even in aged or degraded samples. - While detectable for months, it remains a reliable indicator in semen samples for at least **8-10 weeks** due to its relative stability. *CPK enzyme* - **Creatine phosphokinase (CPK)** is primarily associated with muscle and brain tissue damage, not a specific marker for semen. - It is not routinely traced in semen samples for forensic analysis due to its low specificity. *LDH* - **Lactate dehydrogenase (LDH)** is an enzyme found in various tissues throughout the body, reflecting general cellular damage or metabolism. - It lacks the specificity to be a reliable forensic marker for the presence of semen. *ALP test* - **Alkaline phosphatase (ALP)** is commonly used in clinical settings to assess liver and bone health. - It is not a principal enzyme marker used for the forensic identification of seminal fluid due to its widespread distribution in the body.
Explanation: **1234** - The correct order of sperm formation begins with **spermatogonia**, which are germline stem cells that differentiate into **spermatocytes**. - Spermatocytes then undergo meiosis to become **spermatids**, which finally mature into **spermatozoa** (mature sperm). *2314* - This order is incorrect because it places spermatocytes before spermatogonia and then incorrectly places spermatogonia before spermatids. - **Spermatogonia** are the initial stem cells, preceding spermatocytes in the process. *3214* - This sequence is incorrect as it starts with spermatids, which are an intermediate stage, not the beginning of sperm formation. - **Spermatocytes** develop from spermatogonia and precede spermatids. *3124* - This order incorrectly places spermatids before spermatocytes in the sequence of maturation. - **Spermatocytes** are the cells that undergo meiosis to form spermatids.
Explanation: ***All of the options*** - **Idiopathic**, **varicocele**, and **Yq11 microdeletion** are all recognized causes of male infertility, making this the most comprehensive and correct answer. - Male infertility can stem from a variety of factors, including genetic, structural, hormonal, and unexplained (idiopathic) causes. *Idiopathic* - Refers to cases where no specific cause for infertility can be identified despite thorough investigation, accounting for a significant proportion of male infertility. - This diagnosis is made by **exclusion** after ruling out other known causes. *Varicocele* - A common and treatable cause of male infertility, characterized by **dilated veins in the pampiniform plexus** of the scrotum. - Varicoceles can impair sperm production and function due to **increased scrotal temperature** and oxidative stress. *Yq11 microdeletion* - Refers to deletions in the **azoospermia factor (AZF) region** on the long arm of the Y chromosome, which are genetic causes of severe spermatogenic failure. - These deletions disrupt genes essential for sperm production, leading to conditions ranging from **oligozoospermia** (low sperm count) to **azoospermia** (absence of sperm).
Explanation: ***Obese women in the age group 20-40 yrs.*** - **Pseudotumor cerebri** (also known as idiopathic intracranial hypertension) is most commonly seen in **obese women** of childbearing age, typically between **20 and 40 years old** [1]. - Risk factors include **obesity** and certain medications like **tetracyclines**, **excess vitamin A**, or **oral contraceptives** [1]. *Obese males 20-40 yrs.* - While obesity is a risk factor, **males** are significantly less commonly affected by pseudotumor cerebri than females [1]. - The disease has a strong predilection for the female gender in this age group. *Thin males 50-60 yrs.* - **Pseudotumor cerebri** is rarely observed in individuals who are **thin** and in older age groups like **50-60 years old**. - This demographic does not align with the typical patient profile for this condition. *Thin females 50-60 yrs.* - Similar to thin males, **thin females** in the **50-60 year age group** are not typically affected by pseudotumor cerebri. - The condition primarily impacts young to middle-aged obese women.
Explanation: ***Azoospermia*** - Prolonged exogenous testosterone administration suppresses the **hypothalamic-pituitary-gonadal (HPG) axis**, leading to decreased **gonadotropin-releasing hormone (GnRH)**, then reduced **luteinizing hormone (LH)** and **follicle-stimulating hormone (FSH)**. - Reduced FSH is critical for **spermatogenesis** in the seminiferous tubules, causing a severe reduction or complete absence of sperm in the ejaculate, known as azoospermia. *Decreased spermatogenesis* - While testosterone treatment does lead to decreased spermatogenesis, azoospermia represents the most severe and complete form of this reduction, indicating a total absence of sperm. - Spermatogenesis refers to the general process of sperm production, whereas **azoospermia** specifically describes the clinical outcome of no sperm. *Decreased sperm motility* - Poor sperm motility (**asthenozoospermia**) can occur due to various factors, but prolonged exogenous testosterone primarily affects **sperm production** rather than sperm movement. - Although sperm quality might decline, the most pronounced effect is on the **number of sperm** produced, potentially leading to complete absence. *Decreased gonadotropins* - Decreased gonadotropins (LH and FSH) are an **intermediate step** in the cascade, not the most likely direct consequence on sperm. - The suppression of LH and FSH then leads to the more direct testicular effect of reduced sperm production, ultimately culminating in **azoospermia**.
Explanation: ***High circulating levels of PRL, low levels of LH and FSH, leading to ovarian atrophy.*** - Disruption of the **hypothalamic-pituitary portal system** impairs the transport of **gonadotropin-releasing hormone (GnRH)** to the anterior pituitary, leading to decreased **luteinizing hormone (LH)** and **follicle-stimulating hormone (FSH)**. - This disruption also prevents **dopamine** from reaching the anterior pituitary, leading to uncontrolled **prolactin (PRL)** secretion (disinhibition), which suppresses GnRH and **gonadotropin** release, contributing to **ovarian atrophy**. *Increased follicular development due to elevated circulating levels of PRL.* - Elevated **prolactin (PRL)** levels typically **inhibit** ovarian function and **suppress follicular development**, rather than promoting it. - **Hyperprolactinemia** causes **hypogonadism** by interfering with **GnRH** pulsatility and directly affecting ovarian responsiveness to **gonadotropins**. *Ovulation with subsequent increase in circulating progesterone levels.* - Disruption of the portal system leads to decreased **LH** and **FSH**, which are essential for **follicular development** and **ovulation**. - Without ovulation, a **corpus luteum** cannot form, and therefore, there will be no significant increase in **progesterone** levels. *Increased FSH levels due to reduced ovarian inhibin levels.* - Reduced **FSH** and **LH** levels, resulting from the disruption, would lead to impaired **follicular development** and thus **reduced estrogen** and **inhibin** production by the ovaries. - While reduced inhibin usually leads to increased FSH (negative feedback), the primary impairment in this scenario is at the **hypothalamic-pituitary axis**, directly causing low **gonadotropin** levels, overriding the inhibin effect.
Explanation: ***Inhibition of GnRH pulse secretion*** - **Hyperprolactinemia** directly inhibits the pulsatile release of **gonadotropin-releasing hormone (GnRH)** from the hypothalamus. - This disruption of GnRH pulsatility subsequently impairs the release of **luteinizing hormone (LH)** and **follicle-stimulating hormone (FSH)** from the pituitary, leading to **anovulation** and **amenorrhea**. *Inhibition of adrenal steroidogenesis* - High prolactin levels do not primarily inhibit **adrenal steroidogenesis**; instead, they interfere with the **hypothalamic-pituitary-gonadal (HPG)** axis. - Adrenal steroidogenesis largely involves the production of **androgens**, **glucocorticoids**, and **mineralocorticoids**, which is a separate endocrine pathway. *It causes hypogonadotropic hypogonadism* - While **hyperprolactinemia** *does* lead to **hypogonadotropic hypogonadism**, this option describes the *result* or *consequence* rather than the specific *mechanism* of how it causes amenorrhea. - The fundamental mechanism involves the direct disruption of **GnRH pulsatility** at the hypothalamic level, which then leads to the reduced secretion of gonadotropins. *It leads to decreased ovarian function due to low FSH and LH levels.* - This statement is a downstream effect, not the primary mechanism, just like the previous option. **Low FSH and LH levels** are indeed caused by the initial inhibition of GnRH. - **Decreased ovarian function** is a direct consequence of insufficient **gonadotropin stimulation**, preventing follicular development and estrogen production, which ultimately results in amenorrhea.
Explanation: ***In the adult ovary*** - **Meiosis I** in oocytes starts during fetal development but arrests in prophase I. It resumes and completes in the **adult ovary** just before ovulation in response to hormonal signals. - **Meiosis II** begins after the completion of Meiosis I and arrests in metaphase II. It is only completed upon **fertilization** by a sperm, also occurring within the adult reproductive tract. *At birth in the ovary* - At birth, female ovaries contain primary oocytes that have entered **meiosis I** but are arrested in prophase I; actual meiotic divisions promoting maturation do not occur at this stage. - The completion of meiosis I and the initiation of meiosis II are processes that are **post-puberty** and occur in response to hormonal changes leading to ovulation. *In the adult testis* - The testis is the male gonad, and it is the site of **spermatogenesis**, the process of sperm production involving meiosis in males. - **Oogenesis**, the formation of female gametes, occurs exclusively in the **ovaries** of females. *In the prepubertal testis* - In the prepubertal testis, spermatogenesis has not yet begun, and thus **meiosis does not occur** at this stage in males. - Meiosis in males usually begins during **puberty** under the influence of hormones like testosterone.
Get full access to all questions, explanations, and performance tracking.
Start For Free